Intellia Therapeutics, Inc. (NTLA)

13.59 +0.43 (+3.27%) USD  |  NASDAQ  |  Feb 24, 11:23
More

Intellia Therapeutics EBITDA Estimates for Current Quarter

EBITDA Estimates for Current Quarter Chart

View EBITDA Estimates for Current Quarter for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Estimates for Current Quarter Range, Past 5 Years

View EBITDA Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Estimates for Current Quarter Benchmarks

View EBITDA Estimates for Current Quarter Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Personalis, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Twist Bioscience Corp. Upgrade